Uniphar (LON:UPR) Sets New 52-Week High - Here's Why

Uniphar plc (LON:UPR - Get Free Report)'s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 248 ($3.29) and last traded at GBX 248 ($3.29), with a volume of 29688 shares trading hands. The stock had previously closed at GBX 238.68 ($3.17).

Analysts Set New Price Targets

Separately, Shore Capital reissued a "buy" rating on shares of Uniphar in a research note on Tuesday, February 25th.

Uniphar Price Performance

The company has a market capitalization of £790.66 million, a price-to-earnings ratio of 17.66 and a beta of 0.75. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The company has a 50 day moving average price of GBX 228.42 and a 200 day moving average price of GBX 199.89.

Uniphar Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, May 16th. Investors of record on Thursday, April 24th will be given a €0.01 ($0.01) dividend. This represents a yield of 0.47%. This is a positive change from Uniphar's previous dividend of $0.01. The ex-dividend date of this dividend is Thursday, April 24th. Uniphar's dividend payout ratio (DPR) is presently 13.91%.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.